Trial Updates At ASCO: Approval Of Daratumumab In Combina...

Trial Updates At ASCO: Approval Of Daratumumab In Combination With Revlimid Or Velcade & Dexamethasone
Annual Meeting Photo

Annual Meeting
3 años 113 Visitas
Categoría:
Descripción:
Robert Rifkin MD Of US Oncology Research Discusses Trial Updates At ASCO: Approval Of Daratumumab In Combination With Revlimid Or Velcade & Dexamethasone.